dc.contributor.author | Soedamah-Muthu, SS | en_US |
dc.contributor.author | Livingstone, SJ | en_US |
dc.contributor.author | Charlton-Menys, V | en_US |
dc.contributor.author | Betteridge, DJ | en_US |
dc.contributor.author | Hitman, GA | en_US |
dc.contributor.author | Neil, HAW | en_US |
dc.contributor.author | Bao, W | en_US |
dc.contributor.author | DeMicco, DA | en_US |
dc.contributor.author | Preston, GM | en_US |
dc.contributor.author | Fuller, JH | en_US |
dc.contributor.author | Stehouwer, CDA | en_US |
dc.contributor.author | Schalkwijk, CG | en_US |
dc.contributor.author | Durrington, PN | en_US |
dc.contributor.author | Colhoun, HM | en_US |
dc.contributor.author | Investigators, CARDS | en_US |
dc.date.accessioned | 2016-08-30T09:58:41Z | |
dc.date.available | 2015-03-16 | en_US |
dc.date.issued | 2015-07 | en_US |
dc.date.submitted | 2016-08-03T17:15:16.154Z | |
dc.identifier.issn | 0012-186X | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/14893 | |
dc.description.sponsorship | CARDS was partially funded by Diabetes UK and the
National Health Service Research and Development Forum (England). | en_US |
dc.format.extent | 1494 - 1502 | en_US |
dc.relation.ispartof | DIABETOLOGIA | en_US |
dc.rights | This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http:// creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. | |
dc.subject | Atorvastatin | en_US |
dc.subject | Cardiovascular disease | en_US |
dc.subject | CARDS | en_US |
dc.subject | C-reactiveprotein | en_US |
dc.subject | LDL-cholesterol | en_US |
dc.subject | Statins | en_US |
dc.subject | Type 2 diabetes | en_US |
dc.title | Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial | en_US |
dc.type | Article | |
dc.rights.holder | (c) The Author(s) 2015. | |
dc.identifier.doi | 10.1007/s00125-015-3586-8 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000356528900014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 7 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 58 | en_US |